Impacts of the COVID-19 Pandemic on the CODE ST-Segment Elevation Myocardial Infarction Program: A Quantitative and Qualitative Analysis

Eka Ginanjar, Arif Mansjoer, Lusiani Rusdi, Rizky Ramadantie, Hadiki Habib, Lies Dina Liastuti, Sally Aman Nasution, Idrus Alwi, Abdul Rashid


Background: The code ST-segment elevation myocardial infarction (STEMI) program is an operational standard of integrated service for STEMI patients carried out by Dr. Cipto Mangunkusumo Hospital. The emerging coronavirus disease 2019 (COVID-19) outbreak brought about many changes in the management of healthcare services, including the code STEMI program. This study aimed to evaluate the healthcare service quality of the Code STEMI program during the COVID-19 pandemic based on the Donabedian concept.  Methods: This was a mixed-methods study using quantitative and qualitative analyses. It was conducted at the Dr. Cipto Mangunkusumo Hospital, a national referral hospital in Indonesia. We compared the data of each patient, including response time, clinical outcomes, length of stay, and cost, from two years between 2018–2020 and 2020–2022 as the pre-COVID-19 code STEMI and COVID-19 Code STEMI periods, respectively. Interviews were conducted to determine the quality of services from the perspectives of stakeholders. Results: A total of 195 patients participated in the study: 120 patients in pre-COVID-19 code STEMI and 75 patients in COVID-19 code STEMI. Our results showed that there was a significant increase in patient’s length of stay during the COVID-19 pandemic (4 days vs. 6 days, p < 0.001). Meanwhile, MACE (13% vs. 11%, p = 0.581), the in-hospital mortality rate (8% vs. 5%, p = 0.706), door-to-wire crossing time (161 min vs. 173 min, p = 0.065), door-to-needle time (151 min vs. 143 min p = 0.953), and hospitalization cost (3,490 USD vs. 3,700 USD, p = 0.945) showed no significant changes. In terms of patient satisfaction, patients found code STEMI during COVID-19 to be responsive and excellent. Conclusion: The implementation of the code STEMI program during the COVID-19 pandemic revealed that modified pathways were required because of the COVID-19 screening process. According to the Donabedian model, during the pandemic, the code STEMI program’s healthcare service quality decreased because of a reduction in efficacy, effectiveness, efficiency, and optimality. Despite these limitations attributed to the pandemic, the code STEMI program was able to provide good services for STEMI patients.


COVID-19; STEMI; code STEMI; health care service; Donabedian component


Beig JR, Tramboo NA, Kumar K, et al. Components and determinants of therapeutic delay in patients with acute ST-elevation myocardial infarction: A tertiary care hospital-based study. J Saudi Heart Assoc. 2017;29(1):7–14.

Eagle KA, Goodman SG, Avezum Á, Budaj A, Sullivan CM, López-Sendón J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: Findings from the Global Registry of Acute Coronary Events (GRACE). The Lancet. 2002;359(9304):373–7.

Ginanjar E, Sjaaf AC, Alwi I, et al. The usefulness of the code ST-Segment Elevation Myocardial Infarction Program to improve quality assurance in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2022;165:27–32.

World Health Organization. Coronavirus disease 2019 (COVID-10) Situation Report - 88. 2020 Apr.

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–60.

Donabedian A. An introduction to quality assurance in health care. Oxford University Press, Inc; 2003.

Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–77.

Rattka M, Dreyhaupt J, Winsauer C, et al. Effect of the COVID-19 pandemic on mortality of patients with STEMI: A systematic review and meta-analysis. Heart. 2021;107(6): 482–7.

Saad M, Kennedy KF, Imran H, et al. Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction. JAMA. 2021;326(19):1940.

Firman D, Mangkuanom AS, Iryuza N, et al. Decrease in the number of patients presenting with ST-segment elevation myocardial infarction across catheterization centers in Indonesia during the Coronavirus disease 2019 pandemic. Front Cardiovasc Med. 2021;16(8).

Alhejily W. Impact of the COVID-19 pandemic on patients with acute coronary syndrome: A tertiary center experience with primary percutaneous intervention and early invasive strategy. Cureus. 2021;27.

Mesnier J, Cottin Y, Coste P, et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: A registry study. Lancet Public Health. 2020;5(10):e536–42.

Campo G, Fortuna D, Berti E, et al. In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study. The Lancet Regional Health - Europe. 2021;3:100055.

Abdelaziz HK, Abdelrahman A, Nabi A, et al. Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center. Am Heart J. 2020;226:45–8.

Gramegna M, Baldetti L, Beneduce A, et al. ST-segment–elevation myocardial infarction during COVID-19 pandemic. Circ Cardiovasc Interv. 2020;13(8).

Jain V, Gupta K, Bhatia K, et al. Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021. Trends Cardiovasc Med. 2021; 31(3):135–40.

Jacobs AK, Ali M, Best PJ, et al. Temporary emergency guidance to STEMI systems of care during the COVID-19 pandemic. Circulation. 2020;142(3):199–202.

Xiang D, Xiang X, Zhang W, et al. Management and outcomes of patients with STEMI during the COVID-19 pandemic in China. J Am Coll Cardiol. 2020;76(11):1318–24.

Rangé G, Hakim R, Beygui F, et al. Incidence, delays, and outcomes of STEMI during COVID‐19 outbreak: Analysis from the France PCI registry. J Am Coll Emerg Physicians Open. 2020;1(6):1168–76.

Sturkenboom HN, van Hattem VAE, Nieuwland W, et al. COVID-19-mediated patient delay caused increased total ischaemic time in ST-segment elevation myocardial infarction. Netherlands Heart Journal. 2022;30(2):96–105.

Erol MK. Treatment delays and in-hospital outcomes in acute myocardial infarction during the Covid-19 pandemic: A nationwide study. The Anatolian Journal of Cardiology. 2020.

Purwa, Sucahya K. Barriers to COVID-19 RT-PCR testing in Indonesia: A health policy perspective. 2020.

Showkathali R, Yalamanchi R, Sankeerthana MP, et al. Acute coronary syndrome admissions and outcome during COVID-19 pandemic–Report from a large tertiary center in India. Indian Heart J. 2020;72(6):599–602.

Leng W-X, Yang J-G, Li X-D, et al. Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment–elevation myocardial infarction during the COVID-19 pandemic—The experience from the largest cardiovascular-specific center in China. Int J Cardiol. 2021;329:260–5.

Evans KK, Bekeny JC, Zolper EG, et al. Ensuring quality care in the COVID-19 era: Applying the Donabedian model to tertiary wound care center practices. J Am Podiatr Med Assoc. 2023;113(2).

Uslu A, Stausberg J. Value of the electronic medical record for hospital care: Update from the literature. J Med Internet Res. 2021;23(12):e26323.

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.